Comments on: Geneseeq partners with Jiangsu Vcare PharmaTech to develop a CDx for NTRK inhibitor in China. /geneseeq-partners-with-jiangsu-vcare-pharmatech-to-develop-a-cdx-for-ntrk-inhibitor-in-china/ We see precision medicine as the future of cancer care. Let’s accelerate precision cancer care, together. Wed, 03 Jul 2024 14:26:49 +0000 hourly 1 https://wordpress.org/?v=6.9.4